Nomoto H, Takahashi Y, Takano Y, Yokoyama H, Tsuchida K, Nagai S, Miya A, Kameda H, Cho KY, Nakamura A, Atsumi T.
Effect of switching to once-weekly semaglutide on non-alcoholic fatty liver disease: The SWITCH-SEMA 1 subanalysis Pharmaceutics, in press IF = 5.4, 5-Y IF= 6.0
Komatsumoto M, Nakazawa D, Endo T, Nishio S, Kawamura T, Miyoshi-Harashima A, Takenaka S, Shiratori-Aso S, Kurotori M, Matsuoka N, Atsumi T.
Successful initiation of hemodialysis for a hemophilia A patient with factor VIII inhibitor: a case report and literature review.
CEN Case Rep. 2023 Jul 25.
IF: 1.0
崎山広大, 藤枝雄一郎, 清水智弘, 垂水政人, 大江悠希, 亀田啓, 中沢大悟, 加藤将, 渥美達也.
リウマチ性疾患患者における非定型大腿骨骨折の6例.
日本骨粗鬆症学会雑誌 2023;9(4)
ERA EDTA Cngress (欧州腎臓学/透析移植学会) 2023 ERA Abstract award 上田 雄翔先生
第66回日本腎臓学会学術総会 優秀演題賞 麻生 里佳先生
JCR（日本リウマチ学会）2023_ICW Excellent Abstract Award（国際ワークショップ優秀演題賞） 小住 由衣先生
第96回日本内分泌学会学術集会 愛・内分泌賞 大江 悠希先生
Inhibition of Toll-like receptor 4 and Interleukin-1 receptor prevent
SARS-CoV-2 mediated kidney injury.
Daigo Nakazawa, Yohei Takeda, Masatoshi Kanda, Utano Tomaru, Haruko Ogawa, Takashi Kudo, Satoka Shiratori-Aso, Kanako Watanabe-Kusunoki, Yusho Ueda, Atsuko Miyoshi, Fumihiko Hattanda, Saori Nishio, Ryo Uozumi, Akihiro Ishizu, Tatsuya Atsumi.
Cell Death Discovery. in press
IF: 7.113
Michihiro Kono, Michihito Kono, Tatuya Atsumi.
Angioedema: hereditary or C1-inhibitor deficiency associated with systemic lupus erythematosus?
Scand J Rheumatol. in press
IF: 3.057
Favorable effect of pemafibrate on insulin resistance and β-cell function in subjects with type 2 diabetes and hypertriglyceridemia: a subanalysis of the PARM-T2D study Hiroshi Nomoto, Kenichi Kito, Hiroshi Iesaka, Yuki Oe, Shinichiro Kawata, Kazuhisa Tsuchida, Shingo Yanagiya, Aika Miya, Hiraku Kameda, Kyu Yong Cho, Ichiro Sakuma, Naoki Manda, Akinobu Nakamura, Tatsuya Atsumi Pharmaceutics, in press IF 6.525